MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer-Reference-Cited by-同舟云学术

MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer

Published:2014-09-07 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Molina-Pinelo Sonia,Carnero Amancio,Rivera Fernando,Estevez-Garcia Purificacion,Bozada Juan Manuel,Limon Maria Luisa,Benavent Marta,Gomez Javier,Pastor Maria Dolores,Chaves Manuel,Suarez Rocio,Paz-Ares Luis,de la Portilla Fernando,Carranza-Carranza Andres,Sevilla Isabel,Vicioso Luis,Garcia-Carbonero Rocio

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-656.pdf

Reference39 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61 (2): 69-90. 10.3322/caac.20107.

2. Parkin DM: International variation. Oncogene. 2004, 23 (38): 6329-6340. 10.1038/sj.onc.1207726.

3. Andre T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F, de Gramont A: Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009, 27 (19): 3109-3116. 10.1200/JCO.2008.20.6771.

4. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000, 18 (16): 2938-2947.

5. Cunningham D, Sirohi B, Pluzanska A, Utracka-Hutka B, Zaluski J, Glynne-Jones R, Koralewski P, Bridgewater J, Mainwaring P, Wasan H, Wang JY, Szczylik C, Clingan P, Chan RT, Tabah-Fisch I, Cassidy J: Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer. Ann Oncol. 2009, 20 (2): 244-250.

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of newly synthesized 2-(thiophen-2-yl)-1H-indole derivatives as anticancer agents against HCT-116 cell proliferation via cell cycle arrest and down regulation of miR-25;Scientific Reports;2024-08-29

2. MiR-99a-3p downregulates TRIM21 to promote gastric cancer development;Molecular and Cellular Biochemistry;2024-05-08

3. Synthesis, molecular docking, and anticancer effect of newly synthesized 2- (thiophen-2-yl)-1H-indole derivatives: suppression of HCT-116 Cell proliferation, cell cycle arrest and downregulation of miR-25, C-Myc and IL-6;2023-11-14

4. miRNAs as prognostic predictors in acute myeloid leukemia;Translational Cancer Research;2023-07

5. Inducing apoptosis by using microRNA in radio-resistant prostate cancer: an in-silico study with an in-vitro validation;Molecular Biology Reports;2023-06-09